• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

谁应该接受慢性完全闭塞经皮冠状动脉介入治疗以及何时接受治疗?:对拟行慢性完全闭塞经皮冠状动脉介入治疗患者的循证方法。

Who Should Undergo Chronic Total Occlusions Percutaneous Coronary Intervention and When?: An Evidence-Based Approach to the Patient Referred for Percutaneous Coronary Intervention of Chronic Total Occlusion.

机构信息

Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.

出版信息

Am J Cardiol. 2024 Sep 15;227:18-28. doi: 10.1016/j.amjcard.2024.07.017. Epub 2024 Jul 18.

DOI:10.1016/j.amjcard.2024.07.017
PMID:39032587
Abstract

Chronic total occlusions (CTO) of the coronary arteries are common among patients presenting to the cardiac catheterization laboratory, and data suggests a worse overall prognosis in patients with CTOs. Percutaneous coronary intervention (PCI) of CTOs has been shown to improve anginal symptoms in observational studies and in a limited number of randomized trials. However, CTO PCI has not been shown to lead to a reduction in other important end points such as myocardial infarction or death. Furthermore, despite recent advances in the field, CTO PCI still carries higher risks and a lower likelihood of success compared with non-CTO PCI. Thus, determining which patients may be appropriate for CTO PCI is challenging and must involve a comprehensive risk-benefit analysis and discussion with the patient. Therefore, we review the currently available data regarding CTO PCI, including the clinical outcomes, the role of preprocedural ischemia testing, and various procedural success and risk stratification scores. Finally, we present our approach to the patient referred for CTO PCI.

摘要

冠状动脉慢性完全闭塞(CTO)在就诊于心脏导管实验室的患者中很常见,数据表明 CTO 患者的整体预后更差。观察性研究和少数随机试验表明,经皮冠状动脉介入治疗(PCI)可改善 CTO 患者的心绞痛症状。然而,CTO PCI 并未显示可降低其他重要终点事件(如心肌梗死或死亡)的发生。此外,尽管该领域最近取得了进展,但与非 CTO PCI 相比,CTO PCI 仍然具有更高的风险和更低的成功率。因此,确定哪些患者可能适合进行 CTO PCI 具有挑战性,必须进行全面的风险效益分析,并与患者进行讨论。因此,我们回顾了目前关于 CTO PCI 的可用数据,包括临床结果、术前缺血检测的作用以及各种手术成功率和风险分层评分。最后,我们介绍了我们对接受 CTO PCI 治疗的患者的处理方法。

相似文献

1
Who Should Undergo Chronic Total Occlusions Percutaneous Coronary Intervention and When?: An Evidence-Based Approach to the Patient Referred for Percutaneous Coronary Intervention of Chronic Total Occlusion.谁应该接受慢性完全闭塞经皮冠状动脉介入治疗以及何时接受治疗?:对拟行慢性完全闭塞经皮冠状动脉介入治疗患者的循证方法。
Am J Cardiol. 2024 Sep 15;227:18-28. doi: 10.1016/j.amjcard.2024.07.017. Epub 2024 Jul 18.
2
[Percutaneous coronary intervention for chronic total occlusion: clinical perspectives in 2015].[经皮冠状动脉介入治疗慢性完全闭塞病变:2015年临床视角]
Rev Med Suisse. 2015 May 27;11(476):1172-9.
3
The role of chronic total occlusions in non-infarct-related arteries in acute coronary syndrome patients: a systematic review.急性冠状动脉综合征患者非梗死相关动脉中慢性完全闭塞的作用:系统评价。
Future Cardiol. 2024;20(10):581-590. doi: 10.1080/14796678.2024.2406651. Epub 2024 Oct 9.
4
Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry).慢性完全闭塞经皮冠状动脉介入治疗的操作结果:来自 NCDR(国家心血管数据注册中心)的报告。
JACC Cardiovasc Interv. 2015 Feb;8(2):245-253. doi: 10.1016/j.jcin.2014.08.014.
5
The predictors of successful percutaneous coronary intervention in ostial left anterior descending artery chronic total occlusion.左前降支开口处慢性完全闭塞病变经皮冠状动脉介入治疗成功的预测因素
Catheter Cardiovasc Interv. 2014 Oct 1;84(4):E30-7. doi: 10.1002/ccd.25514. Epub 2014 May 13.
6
Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial.经皮介入治疗 ST 段抬高型心肌梗死合并慢性完全闭塞病变患者:EXPLORE 试验。
J Am Coll Cardiol. 2016 Oct 11;68(15):1622-1632. doi: 10.1016/j.jacc.2016.07.744.
7
Is sex associated with adverse outcomes after percutaneous coronary intervention for CTO?经皮冠状动脉介入治疗慢性完全闭塞病变后,性别与不良结局相关吗?
Int J Cardiol. 2019 Aug 1;288:29-33. doi: 10.1016/j.ijcard.2019.04.033. Epub 2019 Apr 11.
8
Retrograde chronic total occlusion percutaneous coronary intervention using single catheter: A single centre registry.经皮冠状动脉介入治疗逆行慢性完全闭塞:单中心注册研究。
Indian Heart J. 2021 Jul-Aug;73(4):434-439. doi: 10.1016/j.ihj.2021.06.006. Epub 2021 Jul 1.
9
Prognostic value of the age, creatinine, and ejection fraction score for non-infarct-related chronic total occlusion revascularization after primary percutaneous intervention in acute ST-elevation myocardial infarction patients: A retrospective study.急性ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后,年龄、肌酐和射血分数评分对非梗死相关慢性完全闭塞病变血运重建的预后价值:一项回顾性研究
J Interv Cardiol. 2018 Feb;31(1):33-40. doi: 10.1111/joic.12448. Epub 2017 Sep 20.
10
Percutaneous coronary interventions of chronic total -occlusions; a review of clinical indications, treatment strategy and current practice.慢性完全闭塞病变的经皮冠状动脉介入治疗:临床指征、治疗策略及当前实践综述
Acta Cardiol. 2017 Aug;72(4):357-369. doi: 10.1080/00015385.2017.1335080. Epub 2017 Jul 14.